MedMira Inc.
MIR.V
TSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 45.20K | 47.10K | 60.10K | 110.10K | 86.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 45.20K | 47.10K | 60.10K | 110.10K | 86.80K |
| Cost of Revenue | 178.10K | 196.10K | 166.80K | 208.20K | 186.50K |
| Gross Profit | -132.90K | -149.00K | -106.70K | -98.10K | -99.70K |
| SG&A Expenses | 332.40K | 402.10K | 194.70K | 224.00K | 266.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 820.40K | 675.60K | 504.50K | 488.80K | 527.20K |
| Operating Income | -775.20K | -628.50K | -444.40K | -378.70K | -440.40K |
| Income Before Tax | -952.50K | -858.10K | -574.90K | -437.60K | -574.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -952.50K | -858.10K | -574.90K | -437.60K | -574.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -952.50K | -858.10K | -574.90K | -437.60K | -574.60K |
| EBIT | -775.20K | -628.50K | -444.40K | -378.70K | -440.40K |
| EBITDA | -716.60K | -620.60K | -403.80K | -336.80K | -399.00K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 701.73M | 701.69M | 701.73M | 698.09M | 697.45M |
| Average Diluted Shares Outstanding | 701.73M | 701.69M | 701.73M | 698.09M | 697.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
